DOCSLIB.ORG

NATIONAL OBSTETRICS REGISTRY 4Th REPORT

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
NATIONAL OBSTETRICS REGISTRY 4Th REPORT NATIONAL OBSTETRICS REGISTRY - 0 - - - - - 5 - - - - - 10 = = - - - 15 Editors: Ravichandran Jeganathan Shamala Devi Karalasingam A publication of the National Obstetrics Registry and the Clinical Research Centre, Ministray of Health Malaysia NATIONAL OBSTETRICS REGISTRY (NOR) 4th REPORT JAN 2013 – DEC 2015 Editors: Ravichandran Jeganathan Shamala Devi Karalasingam A publication of the National Obstetrics Registry and the Clinical Research Centre, Ministry of Health Malaysia December 2017© National Obstetrics Registry Publisher: Jointly published by the National Obstetrics Registry and the Clinical Research Centre (CRC), Ministry of Health Malaysia. Contact Details: National Obstetrics Registry National Clinical Research Centre 3rd Floor, Dermatology Block General Hospital Kuala Lumpur Jalan Pahang, 50586 Kuala Lumpur, Malaysia. Tel : (603) 40439300/26980310 Fax : (603) 40439500/29911682 Email : [email protected] Website : http://www.acrm.org.my/nor Suggested citation: Ravichandran Jeganathan (Eds). Preliminary Report of National Obstetrics Registry, Jan 2013 – Dec 2015. Kuala Lumpur, Malaysia: National Obstetrics Registry 2013-2015 Disclaimer: Data reported in this report were collected for 3 years period (from Jan 2013 to December 2015). This report is copyrighted. Reproduction and dissemination of this report in part or in whole for research, educational or other non- commercial purposes are authorized without any prior written permission from the copyright holders provided the source is fully acknowledged. Electronic version The electronic version of this report may be downloaded at or http://www.crc.gov.my/publication/report. Funding The National Obstetrics Registry is funded with grants from the Ministry of Health Malaysia (MOH) ISSN No i ACKNOWLEDGEMENT The National Obstetrics Registry (NOR) team would like to give its grateful appreciation to everyone who has helped make this report possible. We would especially like to thank the following: Director General of Health Malaysia for the support and approval to publish this report Our source data providers for their timely data collection and hard work. Steering committee members and governance board for their tireless effort and expertise dedicated to this registry Clinical Research Centre National for its leadership, supervision and technical support. The registry coordinating team and technical support team for their commitment and contribution in preparing this report. ii STEERING COMMITTEE Advisor Dr. Goh Pik Pin Director, National Clinical Research Centre, Kuala Lumpur Hospital. Principal Investigator Dr. J. Ravichandran R Jeganathan Department of Obstetrics & Gynaecology, Sultanah Aminah Hospital, Johor. Project Manager Dr. Shamala Devi Karalasingam National Clinical Research Centre, Kuala Lumpur Hospital. Members Dr.Maimunah Binti Fadzi Dr. Maizuriati Binti Abd. Raman Department of Obstetrics & Gynaecology, Department of Obstetrics & Gynaecology, Malacca Hospital. Tuanku Fauziah Hospital, Kangar, Perlis. Dr. Sukri Bin Ahmad KJ. Ruhaizan Binti Haron Department of Obstetrics & Gynaecology, Department of Obstetrics & Gynaecology, Raja Perempuan Zainab II Hospital, Sultanah Aminah Hospital, Johor. Kelantan. Matron Anita Malek Dr. Wan Abu Bakar Bin Yusoff Department of Obstetrics & Gynaecology, Department of Obstetrics & Gynaecology, Likas Hospital, Sabah Sultanah Nur Zahirah Hospital, Terengganu. Dato‘ Dr.Sudesan Raman Department of Obstetrics & Gynaecology, Tengku Ampuan Afzan Hospital, Pahang. Dr. Malar Kandasamy Department of Obstetrics & Gynaecology, Tengku Ampuan Rahimah Hospital, Selangor. Dr. Muniswaran Ganeshan Department of Obstetrics & Gynaecology, Sarawak General Hospital. iii EDITORIAL BOARD Editors : Dr. J. Ravichandran R Jeganathan Principal Investigator Sultanah Aminah Hospital, Johor Dr. Shamala Devi Karalasingam Project Manager National Clinical Research Centre, Kuala Lumpur General Hospital. Research Officer : Siti Sara Binti Mat Lazim Assistant Project Manager National Clinical Research Centre, Kuala Lumpur General Hospital. Statisticians : Mohamad Adam Bin Bujang Clinical Research Centre, Sarawak General Hospital. Shahrul Aiman Bin Soelar Clinical Research Centre, Sultanah Bahiyah Hospital, Kedah. Nadiah Binti Sa’at Biostatistics Unit, National Clinical Research Centre, Kuala Lumpur General Hospital. Nurakmal Binti Baharum Biostatistics Unit, National Clinical Research Centre, Kuala Lumpur General Hospital. iv SOURCE DATA PROVIDERS & SITE COORDINATORS No SDP Site Coordinators Year 1 General Hospital Kuala Lumpur (HKL) Dr S. Thallainathan 2009-2012 Sr Rohana Binti Mat Noor 2009-2012 Dr Nasuha Binti Yaacob 2013-2014 Sr Jemlah Binti Ahmad 2013-2014 Dr Nurul Khairiyah Khairuddin 2015 Dr Muniswaran Ganeshan 2016-2017 Sr Neani Surayani Hasimin 2015-2017 2 Raja Perempuan Zainab II Hospital (HRPZ II) Dr. Sukri Ahmad 2009-2015 Kelantan Sr Sariah Bt Tais 2009-2015 Dr. Wan Faizah Binti Wan Mohamed 2016-2017 Sr Norhayati Binti Daud 2016-2017 3 Sultanah Nur Zahirah Hospital (HSNZ) Dr Wan Abu Bakar Yusoff 2009-2017 Terengganu Sr Wan Simbok Binti Wan Ali 4 Tengku Ampuan Rahimah Hospital (HTAR) Dr. Malar Kandasamy 2009-2017 Selangor Sr Zaiton Ibrahim 2013-2014 Sr Rosma Anida Binti Ibrahim 2015-2017 5 Sultanah Bahiyah Hospital (HSB) Dr Aw Lin Da 2009 Kedah Dr Rosliza Binti Shafie 2013-2014 Sr. Zarina Binti Man 2009-2015 Dr Rohana Binti Abd Aziz 2015-2017 Sr Ong Chai See 2015-2017 6 Sultanah Aminah Hospital (HSA) Dr. J Ravichandran R Jeganathan 2009-2017 Johor Sr.Ruhaizan Binti Haron 2009-2017 7 Malacca Hospital Dr. Maimunah Bt Fadzil 2009-2017 Sr Chong Guan Khim 2013-2015 Sr. Roslina Binti Md Zin 2015-2017 8 Tuanku Fauziah Hospital (HTF) Dr. Maizuriati Binti. Abd. Rahman 2009-2017 Perlis Sr. Azlina Binti Halip 2009-2017 v No SDP Site Coordinators Year 9 Raja Permaisuri Bainun Hospital (HRPB) Dr Liza Ling Ping 2009-2012 Perak Dr Jumaida Abu Bakar 2013-2017 Sr Thanalecthumi Sinnathamby 2013-2015 Sr Hamimi Mohd Suffian 2016-2017 10 Tengku Ampuan Afzan Hospital (HTAA) Dato‘ Dr.Sudesan Raman 2009-2017 Pahang Sr Norlida Binti Jusoh 2009-2012 Sr Sariha Binti Abdul Razak 2013-2016 Sr Noor Akmal Binti Salihi 2017 11 Tuanku Ja’afar Hospital (HTJ) Dr Nazura Binti Karim 2009-2012 Negeri Sembilan Dr Faridah Hanim Binti Zamzam 2013-2017 Sr. Roszina Binti Basir 2016-2015 Dr Azmy Bin Mohamad Yusoff 2009 12 Pulau Pinang Hospital (HPP) Dr Diong Seng Kwok 2013-2015 Sr. Norida Binti Abu Bakar 2013-2015 Sr Hasmiza Binti Yahaya 2016-2017 13 Hospital Wanita dan Kanak-kanak (HWKK)Likas Dr Carol Lim 2009-2012 Sabah Datuk Dr Soon Ruey 2013-2017 Matron Anita Malek 2009-2017 14 Sarawak General Hospital (HUS) Dr Azah Binti Yusof 2009 Sarawak Dr Muniswaran Ganeshan 2010-2013 Dr. Voon Hian Yian 2013-2017 Matron Kathleen Rose 2014-2017 15 Segamat Hospital Dr Fatimah Zarina Binti Jamaludin 2015-2017 Johor Sr Sharifah Norhayati Binti Syed Nong 2015-2016 Sr Rosfidah Binti Ishak 2017 vi NOR WEB APPLICATION 1. Go to www.acrm.org.my and click on NOR 2. Login to NOR 3. Select Patient and fill up NOR notification and relevant details. 4. Print out reports. ORGANIZATION OF NOR The organizational structure for the registry is depicted below. Sponsor Governance Board Expert Steering Committee/ Panel Technical Support Team Source Data Providers User group (Hospitals) vii LETTER FROM THE PRINCIPAL INVESTIGATOR The National Obstetrics Registry (NOR) is one of the largest obstetric databases in the world to date. Since its inception in 2009, the database has expanded, and I am proud to say that as of October 2016, we have crossed the 1 million mark, which is a major milestone for a rather young registry. NOR data has been presented and quoted at local and international conferences and congresses and it is one of the recognized source of information on Obstetric performance in Malaysia. This 4TH report covers the years 2013 to 2015. In 2015 Hospital Segamat, came on board and its data has been included in this report. The format of this report is different to the previous reports as only one chapter is written focusing on a single theme. We looked at Stillbirth in tandem with World Health Organization’s theme for 2016 “Making every baby count”. In 2016 NOR collaborated with the International Consortium of Health Outcome Measures (ICHOM) based in Harvard, Boston Massachusetts to develop a Standard set of variables which could be used to benchmark performance internationally as well as locally. Posters and oral presentations using NOR data had been presented at local and international conferences namely; International Federation of Gynaecology and Obstetrics (FIGO) at Vancouver Canada, ICHOM conference in London, UK, RCOG World Congress in Birmingham, UK and RCOG World Congress in Cape Town, South Africa, to name a few. Most of our presentations have been shortlisted for honourable mention. Three manuscripts have been published this year of which 2 are in international journals. The total data analysed in this 4th report was 415,021 deliveries. Data cleaning and analysis of this enormous data was undertaken by the CRC team. Kudos to the core team from CRC for all the hard work to make this 4th report a reality. I would like to thank the site coordinators, site assistants and the O&G Heads of Department of the participating hospitals for their dedication and continuous support to NOR. A special mention of thanks to the manager of NOR Dr Shamala for her continued dedication which is instrumental in the success of NOR My heartfelt gratitude to the Director General of Health and the Clinical Research Centre,
Load more

Recommended publications
  • Buku Panduan Jabatan Patologi 2018 HRPZ II
    HOSPITAL RAJA PEREMPUAN ZAINAB II KOTA BHARU KELANTAN Buku Panduan Jabatan Patologi HRPZ II 2018 KATA ALUAN PENGARAH JABATAN KESIHATAN NEGERI KELANTAN Assalamualaikum wbt. dan Salam Sejahtera. Terlebih dahulu, saya ingin merakamkan ucapan terima kasih kepada Jabatan Patologi, Hospital Raja Perempuan Zainab II kerana memberi kesempatan kepada saya untuk memuatkan kata-kata aluan di dalam Buku Panduan Jabatan. Bersyukur ke Hadrat Allah s.w.t. kerana dengan izin dan limpah kurniaNya, Buku Panduan Jabatan Patologi Edisi 2018 dapat diterbitkan dengan jayanya. Syabas dan tahniah kepada semua anggota Jabatan Patologi Hospital Raja Perempuan Zainab II yang telah menggembleng tenaga, pendapat dan pandangan untuk merealisasikan buku panduan ini. Adalah diharapkan agar kesemua hospital, klinik dan klinik kesihatan di Negeri Kelantan akan merujuk ujian- ujian tertentu yang mana tidak dilakukan di fasiliti mereka. Justeru, penerbitan buku panduan yang dilengkapkan dengan maklumat dan pengetahuan ini diharap dapat memberi manfaat kepada semua pelanggan dan anggota hospital. Usaha ini merupakan satu inisiatif dan tindakan proaktif Jabatan Patologi dan rangkaiannya untuk memberi panduan tentang Perkhidmatan Patologi di Hospital Raja Perempuan Zainab II Akhir kata, saya berharap penerbitan buku panduan ini dapat dijadikan sumber rujukan agar usaha- usaha penambahbaikan yang berterusan dapat dilakukan oleh Jabatan Patologi Hospital Raja Perempuan Zainab II. Dalam usaha untuk memantap dan memajukan sistem Perkhidmatan Patologi, Jabatan Kesihatan Negeri Kelantan sentiasa memberi penekanan yang sewajarnya dalam pelaksanaan pelbagai program yang berkaitan dengan Perkhidmatan Patologi. “ Jabatan Patologi Hospital Raja Perempuan Zainab II Sedia Membantu “ DATO’ DR. AHMAD RAZIN BIN DATO’ HAJI AHMAD MAHIR Pengarah Jabatan Kesihatan Negeri Kelantan i Buku Panduan Jabatan Patologi HRPZ II 2018 KATA ALUAN PENGARAH HRPZ II Assalamualaikum wbt.
    [Show full text]
  • Senarai Singkatan Perpustakaan Di Malaysia
    F EDISI KETIGA SENARAI SINGKATAN PERPUSTAKAAN DI MALAYSIA Edisi Ketiga Perpustakaan Negara Malaysia Kuala Lumpur 2018 SENARAI SINGKATAN PERPUSTAKAAN DI MALAYSIA Edisi Ketiga Perpustakaan Negara Malaysia Kuala Lumpur 2018 © Perpustakaan Negara Malaysia 2018 Hak cipta terpelihara. Tiada bahagian terbitan ini boleh diterbitkan semula atau ditukar dalam apa jua bentuk dengan apa cara jua sama ada elektronik, mekanikal, fotokopi, rakaman dan sebagainya sebelum mendapat kebenaran bertulis daripada Ketua Pengarah Perpustakaan Negara Malaysia. Diterbitkan oleh: Perpustakaan Negara Malaysia 232, Jalan Tun Razak 50572 Kuala Lumpur 03-2687 1700 03-2694 2490 03-2687 1700 03-2694 2490 www.pnm.gov.my www.facebook.com/PerpustakaanNegaraMalaysia blogpnm.pnm.gov.my twitter.com/PNM_sosial Perpustakaan Negara Malaysia Data Pengkatalogan-dalam-Penerbitan SENARAI SINGKATAN PERPUSTAKAAN DI MALAYSIA – Edisi Ketiga eISBN 978-983-931-275-1 1. Libraries-- Abbreviations --Malaysia. 2. Libraries-- Directories --Malaysia. 3. Government publications--Malaysia. I. Perpustakaan Negara Malaysia. Jawatankuasa Kecil Senarai Singkatan Perpustakaan di Malaysia. 027.002559 KANDUNGAN Sekapur Sirih .................................................................................................................. i Penghargaan .................................................................................................................. ii Prakata ........................................................................................................................... iii
    [Show full text]
  • 0. GUT 2018 S. Programme & Abstract Book Cover
    Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology For healthcare professional only Please consult local full prescribing information before prescribing. Further information available on request Headache, abdominal pain, constipation, diarrhea, flatulence, nauswa/vomiting. Undesirable effects: is not recommended. If unavoidable, close clinical monitoring is recommended in combination with an increase in the dose of atazanavir to 400 mg with 100 mg of ritonavir. esomeprazole 20 mg should not be exceeded. Precautions: Hypersensitivity to the active substance esomeprazole or to other substituted benzimidazoles or to any of the excipients, nelfinavir. Exclude gastric malignancy prior to treatment Co-administation of esomeprazole with atazanavir Contraindications: administered as a bolus infusion over 30 minutes, followed by a continuous intravenous infusion of 8 mg/h given over 3 days (72 hours). The parenteral treatment period should be followed by oral acid suppression therapy. be given for up to 10 days as part of a full treatment period for the specified indications. Prevention of rebleeding of gastric and duodenal ulcers: following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers, 80 mg should be oesophagitis: 40 mg once daily. Reflux disease (symptomatic treatment): 20mg once daily. Healing of gastric ulcer and prevention of gastric and duodenal ulcer associated with NSAID therapy: 20mg once daily. Treatment with Nexium IV can Dosege: ulcer associated with NSAID therapy and prevention of gastric and duodenal ulcer associated with NSAID therapy. Prevention of rebleeding following therapeutic enddoscopy for acute bleeding gastric or duodenal ulcers. reflux (Esomeprazole) Indications: Nexium 40 mg injection/Infusion. When oral route is not possible or appropriate; treatment of gastroesophageal reflux disease in patients with esophagitis and/or severe symptoms of reflux, healing of gastric ® nausea/vomiting.
    [Show full text]
  • Penyata Rasmi Parlimen Parliamentary Deb Ates
    Jilid I (,r4JTJ T Hari Rabu AI Bil, 31 4jJJi t \K 18hb Julai, 1979 PENYATA RASMI PARLIMEN PARLIAMENTARY DEB ATES DEWAN NEGARA SENATE PARLIMEN KELIMA Fifth Parliament PENGGAL PERTAMA First Session KANDUNGANNYA JAWAPAN-JAWAPAN MULUT BALI PERTANYAAN-PERTANYAAN [Ruangan 3045] USUL: Waktu Mesyuarat dan Urusan yang dibebaskan daripada Peraturan Mesyuarat [Ruangan 3080] RANG UNDANG-UNDANG: Rang Undang-undang Penyelarasan Perindustrian (Pindaan) [Ruangan 3081] Rang Undang-undang Peruntukan Diraja (Pindaan) [Ruangan 31091 Rang Undang-undang Pencen Khas (Raja Permaisuri Agong) [Ruangan 3121] Rang Undang-undang Saraan Hakim (Pindaan) (No. 2) [Ruangan 31331 MALAYSIA PARLIMEN KELIMA-DE WAN NEGARA Penyata Rasmi Parlimen PENGGAL YANG PERTAMA AHLI-AHLI DEWA'rT NEGARA Yang Berhormat Tuan Yang di -Pertua, TUN DATO' HAJI OMAR YOKE-LIN ONG, P.M.N., S.P.M.S ., D.P.M.S . (Dilantik). „ Menteri Tak Berpotfolio, DATO' HAJI MOHAMED BIN NASIR, S. P.M.K., J.M.N., J.P. (Kelantan). „ Menteri Tak Berpotfolio, PENGIRAN OTHMAN BIN HAJI PENGIRAN RAUF (Sabah). „ Tuan (Timbalan) Yang di-Pertua, TAN SRI DATUK S. 0. K. UBAIDULLA, P.S.M., D.P.M.S., J.M.N. (Dilantik). „ Setiausaha Parlimen Kementerian Sains, Teknologi dan Alam Sekitar, TUAN LAW HIENG DING (Dilantik). „ Jeneral TAN SRI HAJI ABDUL HAMID BIN BIDIN, P.S.M., S.P.M.K., D.I.M.P., J.M.N., P.M.P., P.P.T., P.J.K. (Dilantik). „ TUAN HAJI ABDUL LATIP BIN HAJI IDRIS (Dilantik). „ TUAN ABDUL RAZAK BIN ABU SAMAH (Dilantik). „ TAN SRI DATUK HAJI ABDUL RAZAK BIN HAJI HUSAIN, P.S.M., D.S.W., J.S.M., S.M.P.
    [Show full text]
  • Malaysian Journal of Pharmacy (Vol 2 Issue 2)
    PP12684/8/2008 Vol. 2 Issue 2. August 2016 MALAYSIAN JOURNAL of PHARMACY In this issue: Supplement • Proceedings of the 9th National Pharmacy R&D Conference 2016 A Publication of the Malaysian Pharmaceutical Society PP12684/8/2008 Vol. 2 Issue 2. August 2016 MALAYSIAN JOURNAL of PHARMACY In this issue: Supplement • Proceedings of the 9th National Pharmacy R&D Conference 2016 A Publication of the Malaysian Pharmaceutical Society PP12684/8/2008 Vol. 2 Issue 2. August 2016 MALAYSIAN JOURNAL of PHARMACY In this issue: Supplement • Proceedings of the 9th National Pharmacy R&D Conference 2016 A Publication of the Malaysian Pharmaceutical Society EDITORIAL BOARD Malaysian Journal of Pharmacy Vol. 2 Issue 2. August 2016 The Official Journal of the Malaysian Pharmaceutical Society Editor-in-Chief: Assoc Prof Dr Asrul Akmal Shafie Managing Editor: Mr Ho Rhu Yann International Advisory Board: Assoc Prof Dr Chua Siew Siang Prof Dr Mohd Baidi Bahari Associate Editors: Mr Lam Kai Kun Prof Dr Mohamed Azmi Ahmad Hassali Assoc Prof Dr Mohamad Haniki Nik Mohamed Ms Syireen Alwi Prof P T Thomas Dr Wong Tin Wui Assoc Prof Dr Vikneswaran a/l Murugaiyah Prof Dr Yuen Kah Hay Publisher: Malaysian Pharmaceutical Society Malaysian Journal of Pharmacy 16-2 Jalan OP 1/5, 1-Puchong Business Park (the official journal of the Malaysian Off Jalan Puchong Pharmaceutical Society) 47160 Puchong c/o School of Pharmaceutical Sciences Malaysia Universiti Sains Malaysia Tel: 6-03-80791861 11800 Penang Fax: 6-03-80700388 MALAYSIA Homepage: www.mps.org.my Email: [email protected] Email: [email protected] The Malaysian Journal of Pharmacy is a publication of the Malaysian Pharmaceutical Society.
    [Show full text]
  • Csamm 2016 Abstract Book
    CONTENTS 13TH MAY 2016 (FRIDAY) MEET-THE-EXPERTS 1 | Hepatobiliary Advances in understanding acute pancreatitis and their implications – John Windsor (New Zealand) MEET-THE-EXPERTS 2 Controversies in breast conserving surgery – Elisabeth Elder (Australia), Supakorn Rojananin (Thailand), Farhana Fadzli (Malaysia) PLENARY 1 | Keynote Lecture The delivery of health services for tomorrow’s Malaysia: – Challenges and solutions Noor Hisham Abdullah (Director-General of Health, Malaysia) 43RD A M ISMAIL ORATION An unforgettable surgical journey 12 J C Mehta SYMPOSIUM 1 | Colorectal – Beware Greeks Bearing Gifts 1.1 Anastomotic leak: The do’s and don’ts – Akhtar Qureshi (Malaysia) 1.2 Is radical surgery still necessary? The role of fluorescence 13 imaging in intraoperative colorectal cancer staging David Jayne (UK) 1.3 Obstetric anal sphincter injuries (OASIS): Role of the 13 colorectal surgeon Monica Millan (Spain) 1.4 When surgical colleagues ask a favour…Re-operative – surgery for haemorrhoids Ismail Sagap (Malaysia) 1.5 Surgery for advanced colorectal cancer: How far should – one go? Melissa Teo (Singapore) 1 CONTENTS 13TH MAY 2016 (FRIDAY) SYMPOSIUM 2 | Breast Surgery – Less Is More: Last Of The Amazons 2.1 Dilemmas in surgical management of early breast cancer – Yip Cheng Har (Malaysia) 2.2 Risk-reducing mastectomy – Who and how – Elisabeth Elder (Australia) 2.3 Controversies in the management of metastatic breast cancer – Supakorn Rojananin (Thailand) SYMPOSIUM 3 | Vascular – Devil’s Advocate 3.1 The challenges of being a vascular surgeon
    [Show full text]
  • Clinical Trial Protocol
    DNDi-SOF/RDV-01-HCV Protocol version 8.0 dated 18 Mar 2020 CLINICAL TRIAL PROTOCOL Open label phase II/III, multicenter, trial to assess the efficacy, safety, tolerance, and pharmacokinetics of sofosbuvir plus ravidasvir in HCV (+/- HIV) chronically infected adults with no or compensated cirrhosis in Thailand and Malaysia Short title Strategic transformation of the market of HCV treatments (STORM-C-1) Name of product(s) Sofosbuvir 400 mg tablet manufactured by European Egyptian Pharmaceutical Industries (EEPI), Egypt Ravidasvir 200 mg tablet manufactured by Doppel Farmaceutici, Italy Drug Class HCV Direct Acting Agents Antivirals (DAAs) Sofosbuvir (SOF): NS5 B polymerase nucleotide inhibitor Ravidasvir (RDV, formerly PPI-668): NS5 A replication complex inhibitor Phase Phase II/III Indication Chronic Hepatitis C infection [+/- HIV co-infection] Clinical Trial Protocol DNDi-SOF/RDV-01-HCV Number EudraCT Not applicable Co-Sponsors Drugs for Neglected Diseases initiative (DNDi) Ministry of Health Malaysia Ministry of Public Health Thailand National Science and Technology Development Agency (NSTDA) Thailand National Coordinating Thailand: Malaysia: Investigator Dr. Sombat Thanprasertsuk (stage 1) Dr. Soek-Siam Tan Dr. Satawat Thongsawat (stage 2) Clinical Trial Protocol Final version 8.0 dated 18 March 2020 Version / Date Page 1 of 90 Protocol template_Version 1.2 DNDi-SOF/RDV-01-HCV Protocol version 8.0 dated 18 Mar 2020 CONTACT DETAILS 1. Sponsor's medical expert for the trial Medically qualified DNDi Officer Dr. Isabelle Andrieux-Meyer Head of the HCV and Paediatric HIV Clinical Programs Drugs for Neglected Diseases initiative 15 Chemin Louis Dunant, 1202 Geneva, Switzerland Phone: +41 22 906 92 68 2.
    [Show full text]